vs
Generation Bio Co.（GBIO）与Arcadia Biosciences, Inc.（RKDA）财务数据对比。点击上方公司名可切换其他公司
Generation Bio Co.的季度营收约是Arcadia Biosciences, Inc.的1.8倍（$1.6M vs $901.0K），Arcadia Biosciences, Inc.净利率更高（-148.3% vs -346.3%，领先198.0%），Arcadia Biosciences, Inc.同比增速更快（-25.8% vs -78.9%），过去两年Arcadia Biosciences, Inc.的营收复合增速更高（-4.5% vs -25.6%）
Generation Bio Co.是一家临床阶段生物技术企业，专注开发针对罕见及常见遗传疾病的创新非病毒基因疗法，核心管线覆盖肝脏、视网膜疾病适应症，主要在美国市场运营，致力于为存在未满足医疗需求的患者提供潜在一次性治愈方案。
阿卡迪亚生物科学是一家美国上市农业生物技术企业，总部位于加利福尼亚州戴维斯，专注于开发可提升作物品质与产量的作物性状改良技术，该公司部分股权归道德指南针公司所有。
GBIO vs RKDA — 直观对比
营收规模更大
GBIO
是对方的1.8倍
$901.0K
营收增速更快
RKDA
高出53.1%
-78.9%
净利率更高
RKDA
高出198.0%
-346.3%
两年增速更快
RKDA
近两年复合增速
-25.6%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.6M | $901.0K |
| 净利润 | $-5.5M | $-1.3M |
| 毛利率 | — | 21.4% |
| 营业利润率 | -420.8% | -152.8% |
| 净利率 | -346.3% | -148.3% |
| 营收同比 | -78.9% | -25.8% |
| 净利润同比 | 64.0% | 67.1% |
| 每股收益（稀释后） | $-0.82 | $-0.97 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GBIORKDA
| Q4 25 | — | $901.0K | ||
| Q3 25 | $1.6M | $1.3M | ||
| Q2 25 | $765.0K | $1.5M | ||
| Q1 25 | $8.7M | $1.2M | ||
| Q4 24 | $4.2M | $1.2M | ||
| Q3 24 | $7.6M | $1.5M | ||
| Q2 24 | $4.1M | $1.3M | ||
| Q1 24 | $4.1M | $987.0K |
净利润GBIORKDA
| Q4 25 | — | $-1.3M | ||
| Q3 25 | $-5.5M | $856.0K | ||
| Q2 25 | $-20.9M | $-4.5M | ||
| Q1 25 | $-14.8M | $2.6M | ||
| Q4 24 | $-21.4M | $-4.1M | ||
| Q3 24 | $-15.3M | $-1.6M | ||
| Q2 24 | $-20.4M | $1.1M | ||
| Q1 24 | $-74.5M | $-2.4M |
毛利率GBIORKDA
| Q4 25 | — | 21.4% | ||
| Q3 25 | — | 32.1% | ||
| Q2 25 | — | 43.4% | ||
| Q1 25 | — | 43.2% | ||
| Q4 24 | — | 31.9% | ||
| Q3 24 | — | 32.9% | ||
| Q2 24 | — | 51.5% | ||
| Q1 24 | — | 52.3% |
营业利润率GBIORKDA
| Q4 25 | — | -152.8% | ||
| Q3 25 | -420.8% | -88.5% | ||
| Q2 25 | -2995.6% | -34.4% | ||
| Q1 25 | -190.4% | 44.2% | ||
| Q4 24 | -562.6% | -187.7% | ||
| Q3 24 | -236.7% | -114.5% | ||
| Q2 24 | -569.8% | — | ||
| Q1 24 | -1912.6% | -160.9% |
净利率GBIORKDA
| Q4 25 | — | -148.3% | ||
| Q3 25 | -346.3% | 65.7% | ||
| Q2 25 | -2735.0% | -306.4% | ||
| Q1 25 | -169.7% | 216.6% | ||
| Q4 24 | -510.6% | -334.5% | ||
| Q3 24 | -202.7% | -104.9% | ||
| Q2 24 | -499.4% | 81.2% | ||
| Q1 24 | -1836.4% | -245.5% |
每股收益（稀释后）GBIORKDA
| Q4 25 | — | $-0.97 | ||
| Q3 25 | $-0.82 | $0.62 | ||
| Q2 25 | $-3.12 | $-3.26 | ||
| Q1 25 | $-0.22 | $1.90 | ||
| Q4 24 | $4.50 | $-2.99 | ||
| Q3 24 | $-2.29 | $-1.18 | ||
| Q2 24 | $-3.07 | $0.78 | ||
| Q1 24 | $-1.12 | $-1.78 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $89.6M | $4.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $50.6M | $4.1M |
| 总资产 | $121.9M | $6.5M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资GBIORKDA
| Q4 25 | — | $4.6M | ||
| Q3 25 | $89.6M | $5.9M | ||
| Q2 25 | $141.4M | $4.4M | ||
| Q1 25 | $157.6M | $3.2M | ||
| Q4 24 | $185.2M | $4.2M | ||
| Q3 24 | $184.8M | $6.6M | ||
| Q2 24 | $216.9M | $8.1M | ||
| Q1 24 | $219.3M | $8.5M |
股东权益GBIORKDA
| Q4 25 | — | $4.1M | ||
| Q3 25 | $50.6M | $5.4M | ||
| Q2 25 | $54.1M | $4.5M | ||
| Q1 25 | $73.3M | $8.9M | ||
| Q4 24 | $86.2M | $6.2M | ||
| Q3 24 | $104.4M | $10.3M | ||
| Q2 24 | $115.4M | $11.7M | ||
| Q1 24 | $132.0M | $10.6M |
总资产GBIORKDA
| Q4 25 | — | $6.5M | ||
| Q3 25 | $121.9M | $8.6M | ||
| Q2 25 | $179.4M | $7.8M | ||
| Q1 25 | $201.3M | $13.0M | ||
| Q4 24 | $231.2M | $13.5M | ||
| Q3 24 | $248.8M | $15.2M | ||
| Q2 24 | $265.3M | $17.4M | ||
| Q1 24 | $285.9M | $16.0M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-52.7M | $-861.0K |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | 0.0% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流GBIORKDA
| Q4 25 | — | $-861.0K | ||
| Q3 25 | $-52.7M | $-257.0K | ||
| Q2 25 | $-16.8M | $-2.0M | ||
| Q1 25 | $-28.4M | $-1.6M | ||
| Q4 24 | $-15.8M | $-2.2M | ||
| Q3 24 | $-19.5M | $-1.8M | ||
| Q2 24 | $-21.5M | $-2.5M | ||
| Q1 24 | $-31.7M | $-3.2M |
自由现金流GBIORKDA
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $-17.3M | — | ||
| Q1 25 | $-28.6M | — | ||
| Q4 24 | $-16.2M | — | ||
| Q3 24 | $-19.6M | — | ||
| Q2 24 | $-21.5M | $-2.5M | ||
| Q1 24 | $-33.6M | $-3.2M |
自由现金流率GBIORKDA
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -2259.7% | — | ||
| Q1 25 | -327.9% | — | ||
| Q4 24 | -385.9% | — | ||
| Q3 24 | -260.0% | — | ||
| Q2 24 | -526.7% | -188.3% | ||
| Q1 24 | -828.2% | -326.5% |
资本支出强度GBIORKDA
| Q4 25 | — | 0.0% | ||
| Q3 25 | 0.0% | 0.0% | ||
| Q2 25 | 60.0% | 0.0% | ||
| Q1 25 | 2.8% | 0.0% | ||
| Q4 24 | 9.0% | 0.0% | ||
| Q3 24 | 1.2% | 0.0% | ||
| Q2 24 | 0.3% | 0.2% | ||
| Q1 24 | 47.3% | 1.3% |
现金转化率GBIORKDA
| Q4 25 | — | — | ||
| Q3 25 | — | -0.30× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -0.61× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -2.31× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
